Risk of Nephrogenic Systemic Fibrosis in Patients With...

  • Main
  • 2019 / 12
  • Risk of Nephrogenic Systemic Fibrosis in Patients With...
JAMA Internal Medicine 2019 / 12

Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent

Woolen, Sean A., Shankar, Prasad R., Gagnier, Joel J., MacEachern, Mark P., Singer, Lisa, Davenport, Matthew S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
JAMA Internal Medicine
DOI:
10.1001/jamainternmed.2019.5284
Date:
December, 2019
File:
PDF, 409 KB
2019
Conversion to is in progress
Conversion to is failed